Low early termination rate (4.3%) among the first 116 patients completing the study suggests Halneuron® treatment to be well ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results